Osmosis Investment Management UK Ltd bought a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The firm bought 12,950 shares of the biotechnology company

Landscape Capital Management L.L.C. acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,242 shares of the biotechnology compa

Korea Investment CORP acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 38,461 shares of the biotechnology company

Callan Family Office LLC acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,316 shares of the biotechnology company

Clear Harbor Asset Management LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 5,504 shares of the biotechnology company

Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) has received a consensus rating of "Moderate Buy" from the sixteen brokerages that are covering the firm, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold recommendation and thirteen have given a buy recommen

B. Metzler seel. Sohn & Co. AG purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 6,875 shares of the biotechn